Clinical Trial Update: Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating anticoagulation in liver fibrosis associated with hepatitis C; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis

Snippet

Sponsor: Imperial College London | Conditions: Liver Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2020-12-01